UNSPSC 51284302: Florfenicol

This classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula C12H14Cl2FNO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9J97307Y1H, chemically known as 2,2-dichloro-n-(1-(fluoromethyl)-2-hydroxy-2-(4-(methylsulfonyl)phenyl)ethyl)acetamide but generally known as florfenicol, which bears US NIH Compound Identifier 114811. European Medicines Agency schedules Florfenicol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07651MIG.

UNSPSC 51284302 Florfenicol is a Commodity-tier code for a specific veterinary antibiotic; however, the recent state and local procurement activity recorded under this code does not reflect florfenicol purchases. Instead, the opportunities show pharmaceutical procurement for human medications—doxycycline hyclate, ciprofloxacin hydrochloride, and naloxone—suggesting a potential mismatch between the code assignment and the actual work being solicited. State and local governments appear to use this code (or codes near it) when acquiring pharmaceuticals through piggyback and competitive bidding processes, often coordinated through cooperative purchasing vehicles such as MMCAP Infuse or county health departments.

The Illinois Department of Public Health awarded a pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, valued at $2,999,999.11 over three years (12-month initial term plus two renewal options) for doxycycline hyclate 100mg and ciprofloxacin hydrochloride 500mg tablets through an IFB process under MMCAP Infuse. Separately, Seminole County, Florida released an IFB on June 30, 2026 (response deadline July 26, 2023, though the posted date is recent) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building. The issuing bodies span state health departments and county health authorities. Geographic activity is concentrated in the Midwest (Illinois) and Southeast (Florida) in the recent record. The code shows limited recent activity tied explicitly to florfenicol procurement; firms pursuing pharmaceutical supply contracts to state and local health agencies should verify code alignment before bidding, as assignment practices may vary by jurisdiction.